Brain Death Diagnosis Criteria: A Comprehensive Guide for Healthcare Professionals

Introduction

Brain death, a term legally and clinically recognized, has been a subject of medical discourse for decades, formally defined by the Uniform Determination of Death Act (UDDA) in 1981. This article aims to provide an in-depth understanding of brain death for healthcare professionals, encompassing its underlying causes, differentiation from similar conditions, and the detailed diagnostic criteria and procedures.

This guide delves into the contemporary standards and methodologies for diagnosing brain death, emphasizing thorough clinical evaluations, brainstem reflex assessments, and the judicious application of ancillary tests. The objective is to enhance the proficiency of healthcare professionals across various disciplines, promoting a collaborative, interprofessional approach to managing this critical aspect of patient care. Equipping the healthcare team with comprehensive knowledge and skills is crucial for navigating the clinical, ethical, and legal complexities of brain death, ensuring compassionate, high-quality care for patients and their families during profoundly challenging times.

Objectives:

• Identify the various causes and etiologies that can lead to brain death.
• Accurately interpret the findings of a physical examination in patients suspected of brain death.
• Apply the established and appropriate evaluations in diagnosing brain death.
• Emphasize the critical role of interprofessional care coordination in correctly applying the legal and clinical definitions of brain death.

Access free multiple choice questions on this topic.

Defining Brain Death: The Legal and Medical Standard

In the United States, death is legally defined by the Uniform Determination of Death Act (UDDA), established in 1981. According to the UDDA, a determination of death must adhere to accepted medical standards and must meet at least one of the following criteria:

1. Irreversible cessation of circulatory and respiratory functions.
2. Irreversible cessation of all functions of the entire brain, including the brainstem.

The UDDA emerged in the late 1970s as a response to advancements in life support technology. These advancements enabled the maintenance of circulatory and respiratory functions even when all brain function had irreversibly ceased. While the UDDA established the criteria for brain death, it did not specify the “accepted medical standards” for its determination. The American Academy of Neurology (AAN) first addressed this gap by publishing initial standards in 1995, which were subsequently updated in 2010 to reflect current best practices.

The American Academy of Neurology’s position statement on brain death reinforces the UDDA’s definition, emphasizing “irreversible cessation of all functions of the entire brain, including the brainstem.” This determination is made by demonstrating a complete absence of consciousness (coma), brainstem reflexes, and the independent capacity for breathing (apnea), in the absence of any reversible factors.[1] The concept of irreversibility is central to the definition, highlighting that recovery is not possible regardless of medical intervention. This clarification was crucial given the progress in mechanical ventilation and life support during the 20th century, which allowed for prolonged physiological maintenance of patients with severe brain damage in intensive care units (ICUs).[2], [3] Furthermore, the AAN clarifies that “preserved neuroendocrine function may be present despite irreversible injury of the cerebral hemispheres and brainstem and is not inconsistent with the whole brain standard of death.”[1]

The World Health Organization (WHO), in collaboration with an international forum, officially endorsed brain death as the diagnosis of death in 2012.[4] However, it’s important to note that globally, and even within the United States, there is a lack of uniformity in the certification of brain death. Brain death criteria can also vary based on the patient’s age, necessitating adherence to specific country or state guidelines for different age groups.

Public understanding of “brain death” versus “coma” is crucial. Coma can be misconstrued as a limited form of life, whereas brain death signifies complete and irreversible cessation of brain function, equivalent to death itself. This distinction is vital for guiding medical decisions regarding withdrawal of care and preventing unnecessary resource utilization. Parallel to the evolution of brain death criteria is the critical issue of organ transplantation. The “dead donor rule” dictates that organ procurement is ethically permissible only after death has been legally declared. Brain death declaration thus allows for the procurement of viable organs from patients who, despite being brain dead, may still have circulatory and pulmonary function. This remains a topic of ongoing ethical and societal discussion.[5], [6]

Differentiating brain death from other severe brain injuries, such as vegetative and minimally conscious states, is paramount.[7] In vegetative and minimally conscious states, some brain functions persist, offering a potential, albeit sometimes remote, for recovery, especially in cases of traumatic brain injury (TBI). Brain death, in contrast, is an irreversible condition with no possibility of neurological recovery.

Etiology of Brain Death

Brain death is the ultimate consequence of a severe, catastrophic brain injury. It occurs when cerebral perfusion is abruptly lost, typically when intracranial pressure (ICP) exceeds mean arterial pressure (MAP). The cerebral perfusion pressure (CPP) is calculated as: CPP = MAP – ICP. Studies monitoring brain tissue oxygenation in brain death patients have elucidated two primary mechanisms leading to this condition:

1. Global Ischemic/Anoxic Injury: This often results from events like cardiac arrest, severe hypotension, or asphyxiation. The lack of oxygen delivery to the brain initiates a cascade of cellular damage.

2. Increased Intracranial Pressure (ICP): Conditions like traumatic brain injury, intracranial hemorrhage, or large strokes can cause a rapid rise in ICP. This increased pressure compresses brain tissue and blood vessels, leading to reduced or absent cerebral blood flow.

Alt Text: Diagram illustrating the concept of Cerebral Perfusion Pressure (CPP) as the difference between Mean Arterial Pressure (MAP) and Intracranial Pressure (ICP), highlighting the relationship between these pressures in the context of brain death.

Epidemiology of Brain Death

The most frequent causes of brain death, in descending order of occurrence, are:

1. Cardiopulmonary Arrest
2. Traumatic Brain Injury (TBI)
3. Subarachnoid Hemorrhage
4. Intracerebral Hemorrhage

Among patients who experience cardiopulmonary arrest and undergo resuscitation, approximately 8.9% progress to brain death post-resuscitation. For individuals with TBI, the rate of progression to brain death ranges from 2.8% to 6.1%. In cases of intracranial hemorrhage, patients with subarachnoid hemorrhage progress to brain death in 8.5% to 10.7% of cases, while those with intracerebral hemorrhage progress at a rate of 6.1% to 9.6%.[11], [[12]](#article-18522.r12] It is crucial to recognize that brain death, by definition, carries a 100% mortality rate.

Pathophysiology of Brain Death

The physiological processes leading to brain death are remarkably consistent across various underlying causes. Inadequate oxygen supply to brain tissue initiates a detrimental cascade. This hypoxia triggers progressive cerebral edema, which in turn elevates intracranial pressure (ICP). The increased ICP further reduces cerebral perfusion, ultimately leading to brain herniation or complete cessation of cerebral blood flow and aseptic necrosis of brain tissue.

In cases of anoxic brain injury, such as those following cardiopulmonary arrest, insufficient cardiopulmonary resuscitation exacerbates tissue hypoxia. This hypoxic state results in the release of cytotoxic substances that contribute to progressive cerebral edema and the subsequent cascade of events described above.

For TBIs and other intracranial injuries, the primary insult leads to elevated ICP. This increased ICP diminishes cerebral perfusion pressure (CPP), preventing adequate oxygenation of neuronal tissues. This situation initiates a cycle of further injury, edema, and ultimately, the progression to brain death.[3], [[12]](#article-18522.r12]

Histopathological Findings in Brain Death

Postmortem microscopic examination of brain tissue from brain-dead patients reveals varying degrees of neuronal ischemic changes. The cerebral hemispheres and basal ganglia are most commonly affected by severe ischemia, followed by the pons, medulla oblongata, midbrain, and thalamus, in descending order of severity. Autolysis of the cerebellum is also a frequent finding in autopsies of brain-dead individuals.[13] These histopathological changes corroborate the clinical diagnosis of irreversible brain damage.

Clinical Examination: History and Physical Assessment for Brain Death

Once the decision is made to proceed with brain death determination, a rigorous clinical examination is essential. Three core conditions must be definitively assessed and confirmed:

1. Coma: The patient must be in a deep coma, demonstrating complete unresponsiveness to external stimuli. This involves confirming the absence of any purposeful or reflex motor responses to noxious stimuli. Neither eye-opening nor motor reflexes should be elicited in response to pain. It’s important to note that spinal-mediated reflex movements, such as muscle stretch reflexes, may still be present and are not inconsistent with brain death.[[14]](#article-18522.r14] The underlying cause of the coma must be clearly identified through neuroimaging, medical history, physical examination findings, and relevant laboratory investigations. Reversible causes of coma, such as drug overdose or metabolic derangements, must be ruled out.

2. Absence of Brainstem Reflexes: A comprehensive evaluation of brainstem reflexes is crucial. The following cranial nerve (CN) and brainstem reflexes must be meticulously tested and found to be absent for a diagnosis of brain death:[15]

   • Pupillary Response (CN II & III): Pupils should be non-reactive to light, typically fixed and mid-dilated (4-9mm).
   • Corneal Reflex (CN V & VII): There should be no blink reflex in response to corneal stimulation (e.g., with a sterile cotton swab).
   • Oculocephalic Reflex (Doll’s Eyes) (CN III, VI & VIII): In the absence of cervical spine injury, the head is briskly rotated horizontally and vertically. A normal response (present reflex) would be eye movement in the opposite direction of head rotation. In brain death (absent reflex), the eyes remain fixed in mid-position, moving with the head.
   • Oculovestibular Reflex (Cold Caloric) (CN III, VI & VIII): With the head elevated to 30 degrees, 50 mL of ice-cold water is slowly injected into the external auditory canal after confirming the tympanic membrane is intact. A normal response (present reflex) would be slow tonic deviation of the eyes towards the irrigated ear, often with nystagmus in a conscious patient. In brain death (absent reflex), there is no eye movement. Allow 5 minutes between testing each ear.
   • Gag Reflex (CN IX & X): Stimulation of the posterior pharynx with a tongue blade or suction catheter should not elicit a gag or cough reflex.
   • Cough Reflex (CN IX & X): Deep tracheal suctioning should not elicit a cough reflex.
   • Facial Grimacing to Pain (CN V & VII): Firm pressure applied to the supraorbital notch or temporomandibular joint should not elicit facial grimacing or withdrawal.

3. Apnea Test: This test assesses the absence of spontaneous respiratory drive. It should be performed after coma and absence of brainstem reflexes have been confirmed and reversible conditions have been excluded.

Evaluation: Prerequisites and Apnea Testing Procedure for Brain Death Diagnosis

Before proceeding with the clinical diagnosis of brain death, several pre-conditions must be carefully evaluated and met:[16], [17]

• Establish Etiology of Coma: The underlying cause of the coma must be known and be consistent with irreversible brain damage.
• Exclude Reversible Conditions: Conditions that can mimic brain death must be ruled out, including:
  • Severe metabolic, endocrine, and electrolyte imbalances.
  • Acid-base derangements.
  • Hypothermia (core temperature must be >36°C or 96.8°F).
  • Drug intoxication, particularly central nervous system depressants and neuromuscular blocking agents. If drug intoxication is suspected or neuromuscular blocking agents have been recently administered, allow sufficient time for drug clearance (typically five half-lives, adjusted for renal and hepatic function).
• Hemodynamic Stability: Systolic blood pressure (SBP) must be ≥100 mm Hg. Vasopressors can be administered if necessary to achieve this.
• Neurological Examination Requirements: In most US states, a single neurological examination by an attending physician is sufficient. However, some states mandate examinations by two physicians. It is crucial to be aware of and comply with local and institutional policies.

Apnea Testing Procedure (American Academy of Neurology Guidelines):

Apnea testing is performed last in the sequence of brain death evaluations because increasing PaCO2 can elevate ICP and potentially precipitate cerebral herniation in patients with pre-existing intracranial hypertension.

1. Pre-oxygenation: Pre-oxygenate the patient with 100% FiO2 for at least 10 minutes to achieve a PaO2 > 200 mm Hg.
2. Maintain Hemodynamics: Adjust vasopressors as needed to maintain SBP ≥ 100 mm Hg.
3. Reduce Ventilator Rate and PEEP: Decrease ventilator frequency to 10 breaths per minute and reduce positive end-expiratory pressure (PEEP) to 5 cm H2O.
4. Baseline Blood Gas: If SpO2 remains >95%, obtain a baseline arterial blood gas (ABG) to measure PaCO2.
5. Disconnect Ventilator and Deliver Oxygen: Disconnect the patient from the mechanical ventilator. Provide oxygen via insufflation through an endotracheal tube at 100% FiO2 at 6 L/min, positioned near the carina.
6. Observe for Respiratory Movements: Closely observe for any respiratory efforts (abdominal or chest excursions) for 8 to 10 minutes.
7. Repeat Blood Gas: If no respiratory drive is observed after 8-10 minutes, repeat ABG to measure PaCO2.
8. Interpret Apnea Test Result:
   • Positive Apnea Test (Absence of Respiratory Drive): If no respiratory movements are observed and PaCO2 is >60 mm Hg, or if PaCO2 increases by ≥20 mm Hg over baseline (especially relevant in patients with chronic obstructive pulmonary disease), the apnea test is considered positive, indicating absence of respiratory drive controlled by the brainstem.
   • Negative Apnea Test (Presence of Respiratory Drive): If respiratory movements are observed, the apnea test is negative, and brain death cannot be declared based on this testing.

Apnea Test Termination Criteria:

The apnea test must be terminated and considered invalid if any of the following occur:

• Respiratory Movements: Any respiratory effort (abdominal or chest excursions, gasping) is observed.
• Hemodynamic Instability: Systolic blood pressure decreases to <90 mm Hg.
• Hypoxemia: Oxygen saturation (SpO2) drops below 85% for more than 30 seconds.

If the apnea test is aborted due to these reasons, it can be attempted again using a T-piece circuit connected to the endotracheal tube, delivering continuous positive airway pressure (CPAP) of 10 cm H2O and 100% oxygen at 12 L/min.

If coma, absence of brainstem reflexes, and a positive apnea test are all confirmed, the clinical diagnosis of brain death can be established. This diagnostic process is validated and endorsed by leading professional organizations, including the American Academy of Neurology and the World Brain Death Project.[18]

Ancillary Tests in Brain Death Diagnosis

While not always mandatory, ancillary tests can be valuable in confirming brain death, particularly when clinical examination and apnea testing are inconclusive or cannot be reliably performed. Common scenarios where ancillary tests may be considered include:[16], [[3]](#article-18522.r3]

• Apnea testing is inconclusive (e.g., inability to achieve target PaCO2).
• Patient is hemodynamically unstable and cannot tolerate apnea testing.
• Clinical examination is unreliable due to facial trauma or pre-existing conditions.

Types of Ancillary Tests:

1. Cerebral Angiography (Four-Vessel): Considered the gold standard for evaluating cerebral blood flow. Cessation of blood flow to the brain on angiography confirms brain death. Limitations include invasiveness, need to transport the patient to radiology, potential for contrast-induced nephrotoxicity (especially relevant in potential organ donors), and potential for false-negative results if ICP is artificially lowered (e.g., post-surgery or with ventricular shunts).

2. Transcranial Doppler Ultrasonography (TCD): A non-invasive bedside technique to assess blood flow velocity in major intracranial arteries (middle cerebral, vertebral, basilar, anterior cerebral, ophthalmic). Brain death is indicated by absent diastolic flow, small systolic peaks, or reverberating flow. Limitations include examiner dependence, poor acoustic windows due to thick temporal bones, and potential false-negatives with lowered ICP.

3. Computed Tomography Angiography (CTA) and Magnetic Resonance Angiography (MRA) of the Brain: These imaging modalities can demonstrate the absence of cerebral blood flow, providing confirmatory evidence of brain death. CTA is more readily available and faster than MRA.

4. Radionuclide Brain Scan (SPECT Scan): Uses a radiotracer (e.g., 99mTc-HMPAO) to assess cerebral blood flow. In brain death, the “hollow skull phenomenon” – absence of tracer uptake in the cerebral circulation – is observed. False-positive results are possible if imaging is not performed in both anterior and lateral planes.

5. Electroencephalography (EEG): While EEG silence (isoelectric EEG) can support brain death, it is less specific than cerebral blood flow studies. EEG can be affected by medications and hypothermia. However, it can be helpful in conjunction with other findings.

6. Somatosensory Evoked Potentials (SSEPs): In brain death, SSEPs in response to bilateral median nerve stimulation are absent, as are brainstem auditory evoked potentials (BAEPs) in response to auditory stimuli.[[16]](#article-18522.r16] SSEPs can corroborate EEG findings and are less susceptible to drug effects, but hypothermia can still influence results.[20], [[21]](#article-18522.r21]

The choice of ancillary test depends on clinical circumstances, availability, and institutional protocols. It’s crucial to interpret ancillary test results in conjunction with the clinical examination findings.

Alt Text: Image illustrating a transcranial Doppler ultrasound examination being performed on a patient’s head to assess cerebral blood flow as part of brain death evaluation.

Treatment and Management Following Brain Death Diagnosis

Once brain death is definitively diagnosed, the patient is legally and clinically deceased at the time of completion of brain death testing. Subsequent management decisions are guided by patient and family preferences. Options include withdrawal of cardiopulmonary support or proceeding with organ donation if the patient is a suitable donor and has expressed prior consent or if family consent is obtained.

Thorough and accurate documentation of all steps and criteria met during the brain death evaluation is mandatory in the patient’s medical record. Using a standardized checklist is highly recommended to ensure completeness and adherence to established protocols.[10] Clear communication with the patient’s family throughout this process is essential, providing support and information as they navigate this difficult situation.

Differential Diagnosis: Conditions Mimicking Brain Death

Several conditions can mimic brain death and must be carefully excluded before making a diagnosis. These include:

• Vegetative State and Minimally Conscious State: In these conditions, some brain functions are preserved. Unlike brain death, there is potential for neurological recovery, although it may be limited.
• Locked-In Syndrome: Patients are conscious and aware but have near-complete paralysis, often due to pontine stroke. Brainstem reflexes may be preserved, and EEG is not isoelectric.
• Hypothermia: Severe hypothermia can suppress brain function and mimic brain death. Core temperature must be normalized before brain death evaluation.
• Drug Intoxication: Overdoses of CNS depressants can cause deep coma and suppress brainstem reflexes. Adequate time for drug clearance is essential.
• Guillain-Barré Syndrome (GBS) and Critical Illness Polyneuropathy: These neuromuscular disorders can cause profound weakness and areflexia, potentially mimicking brain death in severe cases. However, pupillary reflexes are typically preserved in GBS.
• Delayed Paralytic Clearance: Residual effects of neuromuscular blocking agents can mask neurological function. Sufficient time for drug washout or reversal is necessary.

A meticulous clinical evaluation, including careful history review and appropriate investigations, is crucial to differentiate these conditions from true brain death. When AAN guidelines are rigorously followed, misdiagnosis of brain death is exceedingly rare. Reported cases of misdiagnosis often involve deviations from established guidelines.[10], [[23]](#article-18522.r23]

Prognosis of Brain Death

The prognosis for brain death is unequivocally 100% mortality.[24] Brain death is, by definition, irreversible, and there is no possibility of neurological recovery.

Complications of Brain Death Diagnosis

Complications related to brain death diagnosis primarily arise when established guidelines and protocols for brain death determination are not strictly adhered to. The most significant complication is misdiagnosis – incorrectly diagnosing a condition mimicking brain death as true brain death. This can tragically lead to the premature declaration of death in a patient who was not actually brain dead, with devastating consequences.[25] Rigorous adherence to diagnostic criteria and exclusion of reversible conditions are paramount to prevent such errors.

Deterrence and Patient Education: Communicating with Families

The diagnosis of brain death is profoundly difficult for families to accept. Research suggests that inviting family members to witness the clinical brain death evaluation can aid in their understanding of the diagnosis. Providing multiple meetings involving various members of the healthcare team, including physicians, nurses, clergy, and social workers, can be necessary to support families and facilitate acceptance of the diagnosis.[23] Compassionate and clear communication, along with addressing family questions and concerns, are crucial aspects of care during this sensitive time.

Pearls and Key Considerations in Brain Death Diagnosis

• The essential requirements for brain death diagnosis are: coma of known etiology, absence of all brainstem reflexes, and apnea.
• Strict adherence to the American Academy of Neurology guidelines is paramount for accurate diagnosis.[26]
• Always exclude reversible causes of coma before initiating brain death evaluation.
• Apnea testing must be performed carefully and safely, monitoring for hemodynamic instability and hypoxemia.
• Ancillary tests can be valuable in specific situations but should always be interpreted in the context of the clinical examination.
• Clear and compassionate communication with families is a critical component of care.

Enhancing Healthcare Team Outcomes in Brain Death Management

The determination of brain death requires a collaborative interprofessional team approach. Nurses, physicians, social workers, and clergy play vital roles in coordinating care, communicating with families, and providing emotional support throughout the brain death evaluation and post-diagnosis period. Specialists such as intensivists, neurologists, or neurosurgeons are essential for interpreting clinical examination findings and guiding the diagnostic process. Radiologists may be involved in interpreting ancillary tests.

When organ donation is a consideration, a specially trained organ procurement team should be involved early in the process, ideally after brain death diagnosis is confirmed, to ensure optimal organ viability and ethical considerations are meticulously addressed.[27] This interprofessional collaboration ensures comprehensive and compassionate care, optimizing outcomes for patients and families facing the complexities of brain death. By adhering to established guidelines, ethical principles, legal responsibilities, and fostering effective communication, healthcare professionals can provide the highest standard of care in brain death scenarios, strengthening team performance and improving patient and family outcomes in this sensitive area of medical practice.

Review Questions

(Note: Review questions are present in the original article on StatPearls, accessible via the provided link)

References

1.Russell JA, Epstein LG, Greer DM, Kirschen M, Rubin MA, Lewis A. Brain death, the determination of brain death, and member guidance for brain death accommodation requests: AAN position statement. Neurology. 2019 Jan 28;92(5):228-232. [PubMed: 30602465]
2.A definition of irreversible coma. Report of the Ad Hoc Committee of the Harvard Medical School to Examine the Definition of Brain Death. JAMA. 1968 Aug 05;205(6):337-40. [PubMed: 5694976]
3.Spinello IM. Brain Death Determination. J Intensive Care Med. 2015 Sep;30(6):326-37. [PubMed: 24227449]
4.Shemie SD, Hornby L, Baker A, Teitelbaum J, Torrance S, Young K, Capron AM, Bernat JL, Noel L., The International Guidelines for Determination of Death phase 1 participants, in collaboration with the World Health Organization. International guideline development for the determination of death. Intensive Care Med. 2014 Jun;40(6):788-97. [PMC free article: PMC4028548] [PubMed: 24664151]
5.Capron AM. Brain death–well settled yet still unresolved. N Engl J Med. 2001 Apr 19;344(16):1244-6. [PubMed: 11309642]
6.Truog RD, Miller FG, Halpern SD. The dead-donor rule and the future of organ donation. N Engl J Med. 2013 Oct 03;369(14):1287-9. [PubMed: 24088088]
7.Bernat JL. The natural history of chronic disorders of consciousness. Neurology. 2010 Jul 20;75(3):206-7. [PubMed: 20554939]
8.Machado C. Diagnosis of brain death. Neurol Int. 2010 Jun 21;2(1):e2. [PMC free article: PMC3093212] [PubMed: 21577338]
9.Palmer S, Bader MK. Brain tissue oxygenation in brain death. Neurocrit Care. 2005;2(1):17-22. [PubMed: 16174963]
10.Drake M, Bernard A, Hessel E. Brain Death. Surg Clin North Am. 2017 Dec;97(6):1255-1273. [PubMed: 29132508]
11.Sandroni C, D’Arrigo S, Callaway CW, Cariou A, Dragancea I, Taccone FS, Antonelli M. The rate of brain death and organ donation in patients resuscitated from cardiac arrest: a systematic review and meta-analysis. Intensive Care Med. 2016 Nov;42(11):1661-1671. [PMC free article: PMC5069310] [PubMed: 27699457]
12.Kramer AH, Zygun DA, Doig CJ, Zuege DJ. Incidence of neurologic death among patients with brain injury: a cohort study in a Canadian health region. CMAJ. 2013 Dec 10;185(18):E838-45. [PMC free article: PMC3855144] [PubMed: 24167208]
13.Machado C, Korein J. Neuropathology of brain death in the modern transplant era. Neurology. 2009 Mar 17;72(11):1028; author reply 1028. [PubMed: 19289748]
14.Ivan LP. Spinal reflexes in cerebral death. Neurology. 1973 Jun;23(6):650-2. [PubMed: 4736311]
15.Munakomi S, Al Khalili Y. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Feb 24, 2024. Brainstem Death (Archived) [PubMed: 31869065]
16.Wijdicks EF, Varelas PN, Gronseth GS, Greer DM., American Academy of Neurology. Evidence-based guideline update: determining brain death in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2010 Jun 08;74(23):1911-8. [PubMed: 20530327]
17.Shutter L. Pathophysiology of brain death: what does the brain do and what is lost in brain death? J Crit Care. 2014 Aug;29(4):683-6. [PubMed: 24930369]
18.Greer DM, Shemie SD, Lewis A, Torrance S, Varelas P, Goldenberg FD, Bernat JL, Souter M, Topcuoglu MA, Alexandrov AW, Baldisseri M, Bleck T, Citerio G, Dawson R, Hoppe A, Jacobe S, Manara A, Nakagawa TA, Pope TM, Silvester W, Thomson D, Al Rahma H, Badenes R, Baker AJ, Cerny V, Chang C, Chang TR, Gnedovskaya E, Han MK, Honeybul S, Jimenez E, Kuroda Y, Liu G, Mallick UK, Marquevich V, Mejia-Mantilla J, Piradov M, Quayyum S, Shrestha GS, Su YY, Timmons SD, Teitelbaum J, Videtta W, Zirpe K, Sung G. Determination of Brain Death/Death by Neurologic Criteria: The World Brain Death Project. JAMA. 2020 Sep 15;324(11):1078-1097. [PubMed: 32761206]
19.Saposnik G, Maurino J, Saizar R, Bueri JA. Spontaneous and reflex movements in 107 patients with brain death. Am J Med. 2005 Mar;118(3):311-4. [PubMed: 15745731]
20.Kramer AH. Ancillary testing in brain death. Semin Neurol. 2015 Apr;35(2):125-38. [PubMed: 25839721]
21.Lie SA, Hwang NC. Challenges of Brain Death and Apnea Testing in Adult Patients on Extracorporeal Membrane Oxygenation-A Review. J Cardiothorac Vasc Anesth. 2019 Aug;33(8):2266-2272. [PubMed: 30765209]
22.Chen JA, Driver J, Segar D, Bernstock JD, Gupta S, Gormley W. Medullary Infarction Leading to Locked-In Syndrome Following Lumbar Puncture in a Patient with Basilar Invagination. World Neurosurg. 2020 May;137:292-295. [PubMed: 32068170]
23.Youn TS, Greer DM. Brain death and management of a potential organ donor in the intensive care unit. Crit Care Clin. 2014 Oct;30(4):813-31. [PubMed: 25257743]
24.Bein T, Müller T, Citerio G. Determination of brain death under extracorporeal life support. Intensive Care Med. 2019 Mar;45(3):364-366. [PubMed: 30627781]
25.Maciel CB, Youn TS, Barden MM, Dhakar MB, Zhou SE, Pontes-Neto OM, Silva GS, Theriot JJ, Greer DM. Corneal Reflex Testing in the Evaluation of a Comatose Patient: An Ode to Precise Semiology and Examination Skills. Neurocrit Care. 2020 Oct;33(2):399-404. [PubMed: 31919808]
26.Junn A, Hwang DY. Practice Variability in Determination of Death by Neurologic Criteria for Adult Patients. Yale J Biol Med. 2019 Dec;92(4):719-724. [PMC free article: PMC6913831] [PubMed: 31866786]
27.Souter MJ, Kirschen M. Brain death: optimizing support of the traumatic brain injury patient awaiting organ procurement. Curr Opin Crit Care. 2020 Apr;26(2):155-161. [PubMed: 32068581]

Disclosure: Ryan Starr declares no relevant financial relationships with ineligible companies.

Disclosure: Prasanna Tadi declares no relevant financial relationships with ineligible companies.

Disclosure: Nicholas Pfleghaar declares no relevant financial relationships with ineligible companies.